DAFTAR PUSTAKA

Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained-release oral

morphine in cancer pain: preference, efficacy, and quality of life. The TTS
Fentanyl Comparative Trial Group. J Pain Symptom Manage 1997;13(5):254
61.
American Cancer Society. 2012. Breast Cancer Facts & Figures 2011-2012.
Atlanta: American Cancer Society, Inc.
Aronson, J.K. 2005. Meylers side effect of drugs. The international encyclopedia of
adverse drug reactions and interactions, 5th edition, p. 1346-1356.
Asokumar B, Newman LM, McCarthy RJ, Ivankovich AD, Tuman KJ. Intrathecal
bupivacaine reduces pruritus and prolongs duration of fentanyl analgesia
during labor: a prospective, randomized controlled trial.AnesthAnalg
1998;87(6):130915.
Auret, K. & Schug, S. a, 2013. Pain management for the cancer patient - current
practice and future developments. Best practice & research. Clinical
anaesthesiology, 27(4), pp.54561.
Barancik M. Inadvertent diagnosis of pheochromocytoma after endoscopic
premedication. Dig Dis Sci 1989;34(1):1368.
Baumann, T.J., Strickland, J. 2008. Pain Management. In : Joseph T. Dipiro, Robert
L. Talbert, Gary C. Yee, Gary, R. Matzke, Barbara G. Wells, L. M. Posey,
editors. Pharmacotherapy a pathophysiologic approach, 7th edition, p. 989.
The McGraw-Hill Companies.
Bhowmik, D. et al., 2010. Recent advances in transdermal drug delivery system.
International Journal of PharmTech Research, 2(1), pp.6877.
Biro Peraturan Perundang-undangan Bidang Politik dan Kesejahteraan Rakyat. 2009.
Undang-undang Republik Indonesia Nomor 35 Tahun 2009 tentang
Narkotika. Jakarta.
Bista, S.R. et al., 2015. Saliva versus Plasma for Pharmacokinetic and
Pharmacodynamic Studies of Fentanyl in Patients with Cancer. Clinical
Therapeutics, 37(11), pp.24682475.

78

79

Broadfield L, Banerjee S, Jewers H, Pollett AJ, Simpson J. 2005. Guidelines for the
management of cancer-related pain in adults. Supportive Care Cancer Site
Team, Cancer Care Nova Scotia, p. 9.
Brown, M.T. & Bussell, J.K. 2011. Medication Adherence: WHO Cares?
Caraceni, et al. 2012. Journal of Pain and Symptom Management: Episodic
(breakthrough) pain prevalence in a population of cancer pain patients.
Comparison of clinical diagnoses with the QUDEI-Italian questionnaire for
intense episodic pain, p. 837.
Cassidy, J., Bisset, D., Obe, R.A.J.S. 2002. Oxford handbook of oncology. Oxford
University Press.
Champion, M.C. & Hartnett, M. 1986. Domperidone , a new dopamine antagonist. ,
135, pp.457461.
Cipolle, R.J., Strand, L.M., Morley, P.C. 2012. In: Cipolle, R.J., Strand, L.M., Morley,
P.C, editors. Pharmaceutical care practice: The patient-centered approach to
medication managemen services, 3rd edition. The McGraw-Hill Education,
LLC.
Das UG, Sasidharan P. Bladder retention of urine as a result of continuous
intravenous infusion of fentanyl: 2 case reports. Pediatrics 2001;108(4):1012
15.
Departemen Kesehatan RI. 2015. Keputusan Menteri Kesehatan Republik
Indonesia Nomor HK.02.02/MENKES/363/2015 tentang Perubahan Kedua
atas Keputusan Menteri Kesehatan Nomor 328/MENKES/SK/IX/2013
tentang Formularium Nasional. Jakarta.
Department of Veterans Affairs. 2011. Opioid-induced constipation: a preventable
problem., (June), pp.1316.
Devine, et al., 2013. Automated profile review for transdermal fentanyl to verify
opioid tolerance in the military health system. p. 1241.
Dorak, M.T. & Karpuzoglu, E. 2012. Gender differences in cancer susceptibility:
an inadequately addressed issue. , 3(November), pp.111.

80

European Oncology Nursing Society. 2013. Breakthrough cancer pain guidelines

2013.
Faull. C., Bennet, M., Forbes. K. 2005. The Principels of Pain Management. In: Faull,
C., Carter, Y.H., Daniels, L, editors. Handbook of palliative care, 2nd edition,
p. 123-124. Blackwell Publishing Ltd.
Fausel, C., Medina, P.J. 2008. Cancer Treatment and Chemotherapy. In: Joseph T.
Dipiro, Robert L. Talbert, Gary C. Yee, Gary, R. Matzke, Barbara G. Wells, L.
M. Posey, editors. Pharmacotherapy a pathophysiologic approach, 7th edition,
p. 2086. The McGraw-Hill Companies.
Fudin, J & McLean, M. 2008. Optimizing pain control with fentanyl patch. Diakses
dari http://www.medscape.com/viewarticle/576398, pada tanggal 3 Agustus
2016.
Graham, G.G., Davies, M.J., Mohamudally, A., Scott, K.F. 2013. The modern
pharmacology of paracetamol: therapeutic actions, mechanism of action,
metabolism, toxicity and recent pharmacological findings.
Gurkan Y, Toker K. Prophylactic ondansetron reduces the incidence of intrathecal
fentanyl-induced pruritus. Anesth Analg 2002;95(6):17636.
Holford, N.H.G. Pharmacokinetic & Pharmacodynamics: Rational dosing & the time
course of drug action. In : Katzung, B.G. 2006. Basic and clinical
pharmacology, 10th edition. The McGraw-Hill Companies.
Hollenberg, M.D., Hollenber, S.J.C., Campton, S.J. 2002. Proteinase-activated
receptor activatin peptides (PAR-AP)
International Medication Safety Network. 2008. Medication incidents related to the
use of fentanyl transdermal systems: An international aggregate analysis.
Janssen Pharmaceutical, Inc., 2014. Highlight of prescribing information.
Jefferies, K. & Pharm, D. 2010. Treatment of Neuropathic Pain. , 1(212), pp.425
432.

81

Jones, K.R., Vojir, C.P., Hutt, E., Fink, R. 2007. Determining mild, moderate, and
severe pain equivalency across pain-intensity tools in nursing home residents.
Journal of rehabilitation research and development, 44(2), pp.305314.
Jozwiak-Bebenista, M. & Nowak, J.Z., 2014. Paracetamol: Mechanism of action,
applications and safety concern. Acta Poloniae Pharmaceutica - Drug Research,
71(1), pp.1123.
Karalliedde, L., Clarke, S.F.J.C., Collignon, U., Karalliedde, J. 2010. Adverse drug
interaction. A handbook for prescribers. Macmillan Publishing Solutions.
Kotake Y, Matsumoto M, Ai K, Morisaki H, Takeda J. Additional droperidol, not
butorphanol, augments epidural fentanyl analgesia following anorectal
surgery. J Clin Anesth 2000;12(1):913.
Lame, I. E., Peters, M. L., & Vlaeyen, J. W. 2005. European Journal of Pain : Quality
of life in chronic pain is more associated with beliefs about pain, than with
pain intensity, p. 1524.
Logemann,J.M., Swegle, C. 2006. Management of Common Opioid-Induced
Adverse Effects.
Martin, J. 2009. British National Formullary 57, pp. 236-237. BMJ Group & RPS
Publishing.
Martin, J. 2011. British National Formullary 61, pp. 254 & 268-269. BMJ Group &
The Royal Pharmaceutical Society of Great Britain.
McAuley, D. 2016. Opioid (narcotic) analgesic converter. Diakses dari
http://globalrph.com/narcotic.cgi. pada tanggal 20 Juli 2016.
McEvoy, G.K. 2011. American Hospital Formulary Service: Drug information
essentials. The American Society of Health-System Pharmacist, Inc.
McPherson, M.L. 2009. Demystifying opioid conversion calculations: A guide for
effective dosing, pp. 90. American Society of Health System Pharmacist, Inc.

82

McQuaid, K.R. Drugs used in the treatment of gastrointestinal diseases. In : Katzung,

B.G, editors. 2006. Basic and clinical pharmacology, 12th edition. The
McGraw-Hill Companies.
Melzack R and Wall P. W. 2003. Handbook of pain management, pp. 583. Elsevier
Limited.
Mercadante, S., 2015. Opioid metabolism and clinical aspects. European Journal of
Pharmacology, 769, pp.7178.
Monthly Index

of Medical

Specialities.

2016.

BD

Gard. Diakses

dari

http://www.mims.com/indonesia/druh/inho/bd-hard pada tanggal 23 Juli 2016.

Monthly Index of Medical Specialities. 2016. Vitamin B Complex. Diakses dari
http://www.mims.com/indonesia/druh/inho/bd-hard pada tanggal 23 Juli 2016.
Mounteney, J. et al., 2015. Fentanyls: Are we missing the signs? Highly potent and
on the rise in Europe. International Journal of Drug Policy, 26(7), pp.626631.
Muijsers RB, Wagstaff AJ. Transdermal fentanyl: an updated review of its
pharmacological properties and therapeutic efficacy in chronic cancer pain
control. Drugs 2001;61(15):2289307.
Muller P, Vogtmann C. Three cases with different presentation of fentanyl-induced
muscle rigiditya rare problem in intensive care of neonates. Am J Perinatol
2000;17(1):236.
Mulugeta, L. & Group, P. 2012. Pharmacogenetics of Codeine. US-FDA.
National Cancer Institute. 2016. Risk factor: Age. Diakses dari
http://www.cancer.gov/about-cancer/causes-prevention/risk/age pada tanggal 23
Juli 2016.
Nguyen,L. 2014. Cancer in older adults: Management and prevention. , pp.112.
Nobili, A., Garattini, S. & Mannucci, P.M. 2011. Multiple diseases and
polypharmacy in the elderly: challenges for the internist of the third
millennium. , pp.2844.

83

Nugent M, Davis C, Brooks D, Ahmedzai SH. Long-term observations of patients

receiving transdermal fentanyl after a randomized trial. J Pain Symptom
Manage 2001;21(5):38591. 57.
ONeil, C.K., 2007. Pain Management. In : Marie A. Chisholm-Burns, Barbara G.
Wells, Terry L. Schwinghammer, Patrick M. Malone, Jill M. Kolesar, John C.
Rotschafer, Josepp T. Dipiro, editors. Pharmacotherapy principles and
practice, p. 487. The McGraw-Hill Companies.
Olkkola KT, Palkama VJ, Neuvonen PJ. Ritonavirs role in reducing fentanyl
clearance and prolonging its half-life. Anesthesiology 1999;91(3):6815.
Palkama VJ, Neuvonen PJ, Olkkola KT. The CYP 3A4 inhibitor itraconazole has no
effect on the pharmacokinetics of i.v. fentanyl. Br J Anaesth 1998;81(4):598
600.
Pharmaceutical Care Network Europe Foundation. 2010. Classification for drug
related problems.
Pitkanen MT, Rosenberg PH, Pere PJ, Tuominen MK, Seppala TA. Fentanyl
prilocaine mixture for intravenous regional anaesthesia in patients
undergoing surgery. Anaesthesia 1992;47(5):3958.
Powell, R. a et al., 2010. Pain history and pain assessment. Guide to pain
management in low-resource settings, pp.6778.
Pusat Data dan Informasi Kementrian Kesehatan RI. 2015. Stop kanker, pp. 3.
Ra, M. et al., 2012. Amitriptyline for neuropathic pain and fibromyalgia in adults
( Review ). , (12).
Ravandi, S.Y., Taslimi, Z., Jamshidian, N., Saberi, H., Shams, J., Haghparast, A.
2012. Prediction of Quality of life by Self-Efficacy, Pain Intensity and Pain
Duration in Patient with Pain Disorders,. , 4(2), pp.117124.
Regan, J.M. & Peng, P., 2000. Neurophysiology of cancer pain. Cancer Control,
7(2), pp.111119.
Ri, K.K. & Isi, D. 2013. Pedoman teknis pelayanan paliatif kanker, pp.7-9

84

Schmidt, B.L., Hamamoto, D.T., Simone, D.A., Wilcox, G.L. 2010. Mechanism of
cancer pain. Molecular interventions, 10(3), pp.16478.
Schneider, C., Wisconsin, S.H., Wisconsin, M.L. 2003. Outpatient practice
management tips: Principles of pain management, CM & R2003 : 1 July.
Schumacher, M.A., Basbaum, A.I., Way, W.L. Opioid Analgesics & Antagonist. In :
Katzung, B.G., Masters, S.B., Trevor, A.J, editors. 2011. Basic and clinical
pharmacology, 12th edition. The McGraw-Hill Companies.
Scottish Executive Social Research. 2005. Quality of life and well-being: Measuring
the benefits of culture and sport.
Serlin S, Mendoza T, Nakamura Y., y cols., 1995. When is cancer pain mild,
moderate or severe? Grading pain severity by its interference with function.
Pain, 61(2), pp.277284.
Sindrup, S.H. et al., 2005. Antidepressants in the treatment of neuropathic pain.
Basic & clinical pharmacology & toxicology, 96, pp.399409.
Sloan, P.A., Moulin, D.E., Hays, H. 1998. A Clinical Evaluation of Transdermal
Therapeutic System Fentanyl for the Treatment of Cancer Pain. , 16(2),
pp.102111.
Somers, et al. 2015. Journal of Pain and Symptom Management : A pilot study of a
mobile health pain coping skills training protocol for patients with persistent
cancer pain, p. 553.
Stanley, T.H., Egan, T.D., Aken, A.V. 2008. A tribute to Dr. Paul A.J. Janssen:
Entrepreneur extraordinaire, innovative scientist, and significant contributor
to anesthesiology.
Stanley, Theodore H. 2014. The Journal of Pain: The fentanyl story, p. 1220-1217.
Tatro, D.S. 2003. A to z drug facts. Facts and Comparisons, 2nd edition.
Tay, W & Ho, K. Y., 2009. The Role of Interventional Therapies in Cancer Pain
Management. , 38(11), pp.989997.

85

U.S. Department of Health and Human Services. 2016. Female reproductive

cancers fact sheet.
Vasic, L. & Vojinovic, R., 2008. Treatment and taxonomy of cancer pain is there
a need for a new approach?, 8(4), pp.138143.
Wilkinson, G.R. 2005. Drug Metabolism and Variability among Patients in Drug
Response. , pp.22112221.
Wilmana, P.F., Gan, S. 2012. Analgesik-antipiretik, analgesik-antiinflamasi
nonsteroid, dan obat gangguan sendi lainnya. In: Gunawan, S.G, editor.
Farmakologi dan terapi. Badan Penerbit FKUI.
World Health Organization, 1996. Cancer Pain Relief: With a guide to opioid
availability 2nd edition, p. 14-16.
World Health Organization, 2004. Palliative Care: Symptom management and endof-life care, p.12
World Health Organization, 2013. Essential medicines in palliative, p. 4.
World
Health
Organization,
2015.
Cancer.
Diakses
dari
http://www.who.int/mediacentre/factsheets/fs297/en/, pada 15 September 2015.
World
Health
Organization,
2015.
Cancer.
Diakses
dari
http://www.who.int/cancer/palliative/definition/en/, pada15 September 2015.
World Health Organization. 2006. Information to be included with an application
for inclusion, change or deletion of a medicine in the WHO Model List of
Essential Medicines.
World Health Organization. 2012. WHO guidelines on the pharmacological
treatment of persisting pain in children with medical illnesses. Geneva : WHO
press.
World
Health
Organization.
2015.
Cancer.
http://www.who.int/mediacentre/factsheets/fs297/en/ pada tanggal 23 Juli 2016
Worldwide Palliative Care Alliance, W.H.O., 2014. Global atlas of palliative care at
the end of life.

86

Yaksh, T.L., Wallace, M.S. 2010. Opioids, analgesia and Pain Management. In :
Brunton, L.L., Chabner, B.A., Knollmann, B.C, editors. Goodman and
gilmanss the pharmacological basis of therapeutics, 12 th edition. The
McGraw-Hill Companies.
Zeppetella, G. 2010. Opioids for the management of breakthrough cancer pain in
adults: A systematic review undertaken as part of an EPCRC opioid
guidelines project. , 25(5), pp.516524.